Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Alpha Teknova, Inc. (TKNO)
USD5.40
-0.01 (-0.18%)
US NASDAQ Healthcare Drug Manufacturers - Specialty & Generic
Address
2290 Bert Drive 95023
Hollister, CA, US
Hollister, CA, US
CEO
Stephen Gunstream
Website
teknova.com
IPO
2021-06-25
CIK 1850902 ISIN US02080L1026
Description
Alpha Teknova, Inc. supplies vital scientific reagents to the life sciences sector across both the United States and international markets. These crucial materials play a key role in facilitating the exploration, evolution, and ultimate production of biopharmaceutical goods, such as advanced drug treatments, new vaccines, and molecular diagnostic solutions. The company's product offerings encompass pre-filled media plates designed for cell growth and replication; liquid cell culture media and complementary supplements that promote cellular proliferation; and various molecular biology reagents used for the handling, rehydration, and purification of samples. Teknova caters to a diverse clientele within the life sciences arena, including pharmaceutical companies, biotechnology firms, contract development and manufacturing organizations (CDMOs), in vitro diagnostic businesses, and academic and governmental research facilities. Founded in 1996, Alpha Teknova's main office is situated in Hollister, California.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD5.40
-0.01 (-0.18%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
164.2K
Beta
0.63
Float Shares
10.71M
Free Float %
20.0%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.52% | +2.70% | +35.11% | +78.87% | -14.57% | +0.26% | -46.03% | +94.39% | -84.76% | -84.76% | -84.76% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (3 ratings, all time)
Buy
Price Targets & DCF
Current price
5.40
Ratings Trend (MoM)
67% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 4 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
1.82
Grey zone
Piotroski F-Score
4 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%+7.4% ★ Q1'26: +13.1% (vs Q1'25)
-
EPS growth Drug Manufacturers - Specialty & Generic: +16.5%+43.9% ★ Q1'26: +2.2% (vs Q1'25)
-
FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%-36.4% Q1'26: -32.3% (vs Q1'25)
-
EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%-40.7% Q1'26: -38.8% (vs Q1'25)
-
ROIC Drug Manufacturers - Specialty & Generic: +6.5%-21.1% Q1'26: -22.8% (vs Q1'25)
-
Share dilution Drug Manufacturers - Specialty & Generic: +0.0%+14.4% Q1'26: +0.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×-1.49× Q1'26: -1.35× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 2 EPS Ana. |
Dec 2027 4 Rev. Ana. 2 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
36.89M
est: 35.19M (+4.9%)
|
41.42M
est: 41.23M (+0.4%)
|
36.68M
est: 34.94M (+5.0%)
|
37.75M
est: 37.21M (+1.4%)
|
40.52M
est: 40.13M (+1.0%)
|
43.86M
42.96M – 44.61M
+9.3% YoY
|
50.28M
49.24M – 51.14M
+14.6% YoY
|
68.60M
67.18M – 69.77M
+36.4% YoY
|
85.60M
83.83M – 87.06M
+24.8% YoY
|
| EBITDA |
-9.13M
est: -13.14M (+30.6%)
|
-25.69M
est: -15.40M (-66.8%)
|
-25.54M
est: -16.30M (-56.7%)
|
-19.57M
est: -17.36M (-12.7%)
|
-10.15M
est: -18.72M (+45.8%)
|
-20.46M
-20.81M – -20.04M
-9.3% YoY
|
-23.46M
-23.86M – -22.97M
-14.6% YoY
|
-32.00M
-32.55M – -31.34M
-36.4% YoY
|
-39.94M
-40.62M – -39.11M
-24.8% YoY
|
| EBIT |
-12.01M
est: -17.00M (+29.4%)
|
-28.86M
est: -19.93M (-44.8%)
|
-31.20M
est: -20.77M (-50.2%)
|
-26.15M
est: -22.12M (-18.2%)
|
-16.49M
est: -23.86M (+30.9%)
|
-26.07M
-26.52M – -25.54M
-9.3% YoY
|
-29.89M
-30.40M – -29.27M
-14.6% YoY
|
-40.78M
-41.48M – -39.94M
-36.4% YoY
|
-50.89M
-51.76M – -49.83M
-24.8% YoY
|
| Net Income |
-9.80M
est: -30.60M (+68.0%)
|
-47.47M
est: -59.35M (+20.0%)
|
-36.78M
est: -47.97M (+23.3%)
|
-26.75M
est: -31.16M (+14.2%)
|
-17.26M
est: -17.17M (-0.5%)
|
-18.33M
-18.35M – -17.46M
-6.8% YoY
|
-16.27M
-17.67M – -12.19M
+11.2% YoY
|
-9.09M
-9.29M – -8.85M
+44.1% YoY
|
-2.14M
-2.19M – -2.08M
+76.5% YoY
|
| SGA |
24.17M
est: 25.49M (-5.2%)
|
37.45M
est: 29.87M (+25.4%)
|
34.78M
est: 27.65M (+25.8%)
|
29.47M
est: 29.45M (+0.1%)
|
27.07M
est: 31.75M (-14.7%)
|
34.71M
33.99M – 35.30M
+9.3% YoY
|
39.78M
38.96M – 40.46M
+14.6% YoY
|
54.28M
53.16M – 55.21M
+36.4% YoY
|
67.73M
66.33M – 68.89M
+24.8% YoY
|
| EPS |
-0.35
est: -0.65 (+46.5%)
|
-1.69
est: -1.27 (-33.1%)
|
-1.16
est: -0.90 (-29.0%)
|
-0.57
est: -0.58 (+2.4%)
|
-0.32
est: -0.33 (+2.9%)
|
-0.34
-0.34 – -0.33
-1.8% YoY
|
-0.28
-0.33 – -0.23
+16.8% YoY
|
-0.17
-0.17 – -0.17
+39.1% YoY
|
-0.04
-0.04 – -0.04
+76.5% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-01 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-1.14M
OE per share TTM
-0.02
Owner's Yield
-0.58%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
123.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
16
Total invested
1.06M
Insider transactions (90d)
0
Beneficial owners (>5%)
9
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Telegraph Hill Partners Management Company, LLC | 37.72M | 70.80% | — | 37.72M | — | 37.72M | OO | DELAWARE | 2024-07-19 | ↗ |
| 2 | THP IV Affiliates Fund, LLC | 25.62M | 48.10% | — | 25.62M | — | 25.62M | OO | DELAWARE | 2024-07-19 | ↗ |
| 3 | Telegraph Hill Partners IV Investment Management, LLC | 25.62M | 48.10% | — | 25.62M | — | 25.62M | OO | DELAWARE | 2024-07-19 | ↗ |
| 4 | Telegraph Hill Partners IV, L.P. | 25.62M | 48.10% | — | 25.62M | — | 25.62M | PN | DELAWARE | 2024-07-19 | ↗ |
| 5 | THP V Affiliates Fund, LLC | 12.10M | 22.70% | — | 12.10M | — | 12.10M | OO | DELAWARE | 2024-07-19 | ↗ |
| 6 | Telegraph Hill Partners V Investment Management, LLC | 12.10M | 22.70% | — | 12.10M | — | 12.10M | OO | DELAWARE | 2024-07-19 | ↗ |
| 7 | Telegraph Hill Partners V, L.P. | 12.10M | 22.70% | — | 12.10M | — | 12.10M | PN | DELAWARE | 2024-07-19 | ↗ |
| 8 | Irene Davis | 3.57M | 12.80% | — | 3.57M | — | 3.57M | IN | United States | 2022-02-14 | ↗ |
| 9 | Ted Davis | 3.57M | 12.80% | — | 3.57M | — | 3.57M | IN | United States | 2022-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
16
-53 vs prev Q
New positions
6
Closed positions
59
Increased
11
Reduced
0
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | ROUBAIX CAPITAL, LLC | 998.5K +164.7K (+19.8%) | 3.79M -1.4M (-26.5%) | 1.87% +0.306 pp | 1.62% -0.786 pp | USD5.23 -27.3% | 6 qtrs — |
| 2 | BALYASNY ASSET MANAGEMENT L.P. | 987.2K -29.0 (0.0%) | 3.75M -2.4M (-38.6%) | 1.84% -0.002 pp | 0.00% -0.003 pp | USD3.19 +19.1% | 12 qtrs — |
| 3 | UBS GROUP AG | 737.3K -764.9K (-50.9%) | 2.80M -6.5M (-69.9%) | 1.38% -1.433 pp | 0.00% -0.001 pp | USD7.33 -48.2% | 19 qtrs — |
| 4 | BLACKROCK, INC. | 730.9K +36.8K (+5.3%) | 2.78M -1.5M (-35.4%) | 1.37% +0.067 pp | 0.00% +0.000 pp | USD5.27 -27.9% | 6 qtrs — |
| 5 | VANGUARD GROUP INC | 593.1K -32.4K (-5.2%) | 2.25M -1.6M (-41.8%) | 1.11% -0.062 pp | 0.00% +0.000 pp | USD12.21 -68.9% | 19 qtrs — |
| 6 | CONESTOGA CAPITAL ADVISORS, LLC | 317.1K +8.1K (+2.6%) | 1.20M -707.4K (-37.0%) | 0.59% +0.015 pp | 0.02% -0.010 pp | USD6.47 -41.3% | 18 qtrs — |
| 7 | ROYCE & ASSOCIATES LP | 293.6K +293.6K (+100.0%) | 1.12M +1.1M (+100.0%) | 0.55% +0.549 pp | 0.01% +0.011 pp | USD3.80 +0.0% | 1 qtrs NEW |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 287.4K +3.0K (+1.1%) | 1.09M -668.5K (-38.0%) | 0.54% +0.005 pp | 0.00% +0.000 pp | USD8.43 -54.9% | 18 qtrs — |
| 9 | BANK OF AMERICA CORP /DE/ | 227.1K +1.4K (+0.6%) | 862.9K -534.4K (-38.2%) | 0.42% +0.002 pp | 0.00% +0.000 pp | USD3.85 -1.3% | 18 qtrs — |
| 10 | MASSAR CAPITAL MANAGEMENT, LP | 200.0K +— (+0.0%) | 760.0K -478.0K (-38.6%) | 0.37% -0.001 pp | 0.08% -0.081 pp | USD5.01 -24.2% | 4 qtrs — |
| 11 | STATE STREET CORP | 156.5K -992.0 (-0.6%) | 594.8K -380.2K (-39.0%) | 0.29% -0.002 pp | 0.00% +0.000 pp | USD7.03 -45.9% | 18 qtrs — |
| 12 | BANK OF NEW YORK MELLON CORP | 119.1K +1.0K (+0.9%) | 452.5K -278.2K (-38.1%) | 0.22% +0.002 pp | 0.00% 0.000 pp | USD4.93 -22.9% | 3 qtrs — |
| 13 | KESTRA PRIVATE WEALTH SERVICES, LLC | 105.7K +26.0K (+32.7%) | 401.6K -91.5K (-18.6%) | 0.20% +0.048 pp | 0.01% -0.001 pp | USD5.86 -35.2% | 5 qtrs — |
| 14 | NORTHERN TRUST CORP | 90.8K -10.2K (-10.1%) | 345.2K -280.1K (-44.8%) | 0.17% -0.019 pp | 0.00% +0.000 pp | USD7.78 -51.2% | 18 qtrs — |
| 15 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 80.9K +— (+0.0%) | 307.4K -193.4K (-38.6%) | 0.15% 0.000 pp | 0.01% -0.004 pp | USD4.59 -17.2% | 13 qtrs — |
| 16 | DIVISADERO STREET CAPITAL MANAGEMENT, LP | 78.9K +— (+0.0%) | 299.7K -188.5K (-38.6%) | 0.15% 0.000 pp | 0.01% -0.007 pp | USD5.19 -26.8% | 4 qtrs — |
| 17 | MORGAN STANLEY | 75.7K -31.9K (-29.6%) | 287.5K -378.0K (-56.8%) | 0.14% -0.060 pp | 0.00% +0.000 pp | USD4.74 -19.8% | 19 qtrs — |
| 18 | MOUNT LUCAS MANAGEMENT LP | 70.0K +— (+0.0%) | 266.0K -167.3K (-38.6%) | 0.13% 0.000 pp | 0.11% -0.072 pp | USD5.56 -31.7% | 5 qtrs — |
| 19 | CITADEL ADVISORS LLC | 68.4K +68.4K (+100.0%) | 259.7K +259.7K (+100.0%) | 0.13% +0.128 pp | 0.00% +0.000 pp | USD3.80 +0.0% | 7 qtrs — |
| 20 | APOLLO MANAGEMENT HOLDINGS, L.P. | 65.0K +— (+0.0%) | 247.1K -155.4K (-38.6%) | 0.12% 0.000 pp | 0.00% -0.002 pp | USD8.35 -54.5% | 5 qtrs — |
| 21 | JANE STREET GROUP, LLC | 62.9K +62.9K (+100.0%) | 239.0K +239.0K (+100.0%) | 0.12% +0.118 pp | 0.00% +0.000 pp | USD3.80 +0.0% | 1 qtrs NEW |
| 22 | TWO SIGMA INVESTMENTS, LP | 61.5K +24.5K (+66.1%) | 233.6K +4.5K (+2.0%) | 0.11% +0.046 pp | 0.00% +0.000 pp | USD4.47 -15.0% | 6 qtrs — |
| 23 | SQUAREPOINT OPS LLC | 60.6K -23.0K (-27.5%) | 230.2K -287.4K (-55.5%) | 0.11% -0.043 pp | 0.00% 0.000 pp | USD6.19 -38.6% | 6 qtrs — |
| 24 | GOLDMAN SACHS GROUP INC | 55.0K -5.1K (-8.5%) | 209.2K -163.2K (-43.8%) | 0.10% -0.010 pp | 0.00% +0.000 pp | USD5.62 -32.4% | 5 qtrs — |
| 25 | MARSHALL WACE, LLP | 50.2K +37.2K (+286.1%) | 190.6K +110.2K (+137.0%) | 0.09% +0.069 pp | 0.00% +0.000 pp | USD4.13 -8.0% | 6 qtrs — |
| 26 | TRADEWINDS, LLC. | 48.8K -107.7K (-68.8%) | 185.5K -783.5K (-80.9%) | 0.09% -0.202 pp | 0.04% -0.192 pp | USD6.19 -38.6% | 5 qtrs — |
| 27 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 38.8K +22.6K (+139.3%) | 147.4K +47.1K (+46.9%) | 0.07% +0.042 pp | 0.00% +0.000 pp | USD5.23 -27.3% | 9 qtrs — |
| 28 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 34.3K +28.0 (+0.1%) | 130.3K -81.8K (-38.6%) | 0.06% +0.000 pp | 0.00% +0.000 pp | USD4.91 -22.6% | 3 qtrs — |
| 29 | — | 32.6K +32.6K (+100.0%) | 123.9K +123.9K (+100.0%) | 0.06% +0.061 pp | 0.15% +0.154 pp | USD3.80 +0.0% | 1 qtrs NEW |
| 30 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 29.7K +— (+0.0%) | 112.9K -71.0K (-38.6%) | 0.06% 0.000 pp | 0.00% -0.001 pp | USD5.03 -24.5% | 4 qtrs — |
| 31 | FIELDER CAPITAL GROUP LLC | 25.2K +3.0 (+0.0%) | 95.6K -60.1K (-38.6%) | 0.05% 0.000 pp | 0.02% -0.015 pp | USD3.73 +1.9% | 9 qtrs — |
| 32 | TWO SIGMA SECURITIES, LLC | 22.6K +22.6K (+100.0%) | 86.0K +86.0K (+100.0%) | 0.04% +0.042 pp | 0.01% +0.012 pp | USD3.80 +0.0% | 1 qtrs NEW |
| 33 | BARCLAYS PLC | 20.3K +336.0 (+1.7%) | 77.3K -46.5K (-37.6%) | 0.04% +0.001 pp | 0.00% +0.000 pp | USD6.38 -40.4% | 5 qtrs — |
| 34 | XTX TOPCO LTD | 20.1K +20.1K (+100.0%) | 76.5K +76.5K (+100.0%) | 0.04% +0.038 pp | 0.00% +0.002 pp | USD3.80 +0.0% | 1 qtrs NEW |
| 35 | DEUTSCHE BANK AG\ | 14.4K +— (+0.0%) | 54.8K -34.5K (-38.6%) | 0.03% +0.000 pp | 0.00% +0.000 pp | USD5.12 -25.8% | 3 qtrs — |
| 36 | NUVEEN, LLC | 14.2K +— (+0.0%) | 53.8K -33.8K (-38.6%) | 0.03% +0.000 pp | 0.00% +0.000 pp | USD4.91 -22.6% | 3 qtrs — |
| 37 | RHUMBLINE ADVISERS | 13.9K -1.7K (-10.8%) | 52.7K -43.5K (-45.2%) | 0.03% -0.003 pp | 0.00% +0.000 pp | USD4.91 -22.6% | 3 qtrs — |
| 38 | SHERBROOKE PARK ADVISERS LLC | 12.9K -2.2K (-14.8%) | 49.2K -44.8K (-47.7%) | 0.02% -0.004 pp | 0.13% +0.083 pp | USD6.19 -38.6% | 2 qtrs — |
| 39 | NEW YORK STATE COMMON RETIREMENT FUND | 12.5K -7.1K (-36.2%) | 47.5K -73.8K (-60.8%) | 0.02% -0.013 pp | 0.00% 0.000 pp | USD4.91 -22.6% | 3 qtrs — |
| 40 | WELLS FARGO & COMPANY/MN | 11.9K +3.6K (+43.8%) | 45.2K -6.0K (-11.7%) | 0.02% +0.007 pp | 0.00% +0.000 pp | USD4.84 -21.5% | 3 qtrs — |
| 41 | DIMENSIONAL FUND ADVISORS LP | 11.8K +435.0 (+3.8%) | 44.7K -24.1K (-35.1%) | 0.02% +0.001 pp | 0.00% +0.000 pp | USD3.07 +23.8% | 14 qtrs — |
| 42 | PROSHARE ADVISORS LLC | 10.0K +10.0K (+100.0%) | 38.0K +38.0K (+100.0%) | 0.02% +0.019 pp | 0.00% +0.000 pp | USD3.80 +0.0% | 1 qtrs NEW |
| 43 | CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 8.7K -657.0 (-7.0%) | 33.1K -24.9K (-42.9%) | 0.02% -0.001 pp | 0.00% -0.002 pp | USD8.34 -54.4% | 5 qtrs — |
| 44 | JPMORGAN CHASE & CO | 7.9K +185.0 (+2.4%) | 30.2K -17.9K (-37.1%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD6.23 -39.0% | 18 qtrs — |
| 45 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 5.1K +176.0 (+3.6%) | 19.3K -11.0K (-36.4%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD4.87 -22.0% | 3 qtrs — |
| 46 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 4.3K +— (+0.0%) | 16.4K -10.3K (-38.6%) | 0.01% +0.000 pp | 0.00% 0.000 pp | USD6.19 -38.6% | 2 qtrs — |
| 47 | BNP PARIBAS ARBITRAGE, SNC | 3.8K +662.0 (+20.8%) | 14.6K -5.1K (-25.8%) | 0.01% +0.001 pp | 0.00% +0.000 pp | USD5.89 -35.5% | 5 qtrs — |
| 48 | TOWER RESEARCH CAPITAL LLC (TRC) | 2.9K +985.0 (+52.4%) | 10.9K -750.0 (-6.4%) | 0.01% +0.002 pp | 0.00% 0.000 pp | USD4.71 -19.3% | 4 qtrs — |
| 49 | MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 2.6K +532.0 (+25.7%) | 9.9K -2.9K (-22.8%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD7.03 -45.9% | 5 qtrs — |
| 50 | LARSON FINANCIAL GROUP LLC | 2.5K -6.9K (-73.1%) | 9.6K -48.5K (-83.5%) | 0.00% -0.013 pp | 0.00% -0.002 pp | USD5.56 -31.7% | 4 qtrs — |
| 51 | CREDIT INDUSTRIEL ET COMMERCIAL | 2.0K +— (+0.0%) | 7.6K -4.8K (-38.6%) | 0.00% +0.000 pp | 0.00% -0.001 pp | USD8.35 -54.5% | 5 qtrs — |
| 52 | CITIGROUP INC | 1.7K -38.0 (-2.1%) | 6.6K -4.4K (-39.9%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD4.90 -22.4% | 18 qtrs — |
| 53 | RUSSELL INVESTMENTS GROUP, LTD. | 1.3K +335.0 (+35.8%) | 4.8K -963.0 (-16.6%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD5.56 -31.7% | 2 qtrs — |
| 54 | LEGAL & GENERAL GROUP PLC | 1.2K +— (+0.0%) | 4.6K -2.9K (-38.6%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.91 -22.6% | 3 qtrs — |
| 55 | AMERITAS INVESTMENT PARTNERS, INC. | 1.1K +— (+0.0%) | 4.2K -2.6K (-38.6%) | 0.00% +0.000 pp | 0.00% 0.000 pp | USD4.91 -22.6% | 3 qtrs — |
| 56 | GF FUND MANAGEMENT CO. LTD. | 1.1K -94.0 (-8.2%) | 4.0K -3.1K (-43.7%) | 0.00% 0.000 pp | 0.00% 0.000 pp | USD7.78 -51.2% | 5 qtrs — |
| 57 | ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 906.00 +— (+0.0%) | 3.4K -2.2K (-38.6%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.19 -26.8% | 4 qtrs — |
| 58 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 666.00 -12.0 (-1.8%) | 2.5K -1.7K (-39.7%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.91 -22.6% | 3 qtrs — |
| 59 | FMR LLC | 575.00 +65.0 (+12.7%) | 2.2K -972.0 (-30.8%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD6.56 -42.1% | 5 qtrs — |
| 60 | VERMILLION & WHITE WEALTH MANAGEMENT GROUP, LLC | 423.00 +— (+0.0%) | 1.6K -1.0K (-38.6%) | 0.00% +0.000 pp | 0.00% -0.001 pp | USD4.91 -22.6% | 3 qtrs — |
| 61 | ROYAL BANK OF CANADA | 387.00 -106.0 (-21.5%) | 1.0K -2.0K (-66.7%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD5.24 -27.5% | 3 qtrs — |
| 62 | AMALGAMATED BANK | 341.00 -29.0 (-7.8%) | 1.0K -1.0K (-50.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD4.91 -22.6% | 3 qtrs — |
| 63 | DAIWA SECURITIES GROUP INC. | 300.00 +— (+0.0%) | 1.0K -1.0K (-50.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.19 -26.8% | 4 qtrs — |
| 64 | GAMMA INVESTING LLC | 140.00 +140.0 (+100.0%) | 532.00 +532.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.80 +0.0% | 1 qtrs NEW |
| 65 | STERLING CAPITAL MANAGEMENT LLC | 112.00 +41.0 (+57.7%) | 426.00 -13.0 (-3.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.81 -21.0% | 3 qtrs — |
| 66 | PNC FINANCIAL SERVICES GROUP, INC. | 106.00 +106.0 (+100.0%) | 403.00 +403.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.79 +0.3% | 1 qtrs NEW |
| 67 | SIMPLEX TRADING, LLC | 48.00 +48.0 (+100.0%) | 182.00 +182.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.79 +0.3% | 1 qtrs NEW |
| 68 | SBI SECURITIES CO., LTD. | 13.00 +13.0 (+100.0%) | 49.00 +49.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.77 +0.8% | 1 qtrs NEW |
| 69 | ALLWORTH FINANCIAL LP | 1.00 +1.0 (+100.0%) | 4.00 +4.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.00 +26.7% | 1 qtrs NEW |
| 70 | SRS CAPITAL ADVISORS, INC. | — -62.0 (-100.0%) | — -383.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 71 | PHARVISION ADVISERS, LLC | — -37.6K (-100.0%) | — -233.0K (-100.0%) | 0.00% -0.070 pp | 0.00% -0.131 pp | USD— | 3 qtrs SOLD |
| 72 | QUARRY LP | — -6.9K (-100.0%) | — -42.4K (-100.0%) | 0.00% -0.013 pp | 0.00% -0.009 pp | USD— | 3 qtrs SOLD |
| 73 | MILLENNIUM MANAGEMENT LLC | — -36.1K (-100.0%) | — -223.4K (-100.0%) | 0.00% -0.068 pp | 0.00% 0.000 pp | USD— | 19 qtrs SOLD |
| 74 | SANCTUARY ADVISORS, LLC | — -52.8K (-100.0%) | — -274.1K (-100.0%) | 0.00% -0.099 pp | 0.00% -0.002 pp | USD— | 4 qtrs SOLD |
| 75 | NATIONAL BANK OF CANADA /FI/ | — -24.0K (-100.0%) | — -147.8K (-100.0%) | 0.00% -0.045 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 76 | ENGINEERS GATE MANAGER LP | — -10.1K (-100.0%) | — -62.8K (-100.0%) | 0.00% -0.019 pp | 0.00% -0.001 pp | USD— | 2 qtrs SOLD |
| 77 | EHP FUNDS INC. | — -88.0K (-100.0%) | — -545.0K (-100.0%) | 0.00% -0.165 pp | 0.00% -0.481 pp | USD— | 2 qtrs SOLD |
| 78 | WEXFORD CAPITAL LP | — -49.4K (-100.0%) | — -305.6K (-100.0%) | 0.00% -0.092 pp | 0.00% -0.044 pp | USD— | 4 qtrs SOLD |
| 79 | WHALEN WEALTH MANAGEMENT INC. | — -12.4K (-100.0%) | — -76.7K (-100.0%) | 0.00% -0.023 pp | 0.00% -0.045 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 47 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Invesco NASDAQ Biotech UCITS ETF SBIO.L | 0.02% | 91.2K | 0.40% |
| 2 | Invesco Nasdaq Biotechnology ETF IBBQ | 0.02% | 14.8K | 0.19% |
| 3 | iShares Nasdaq US Biotechnology UCITS ETF BTEC.L | 0.02% | 199.8K | 0.35% |
| 4 | iShares Nasdaq US Biotechnology UCITS ETF BTEE.L | 0.02% | 13.4K | 0.35% |
| 5 | iShares Micro-Cap ETF IWC | 0.01% | 202.2K | 0.60% |
| 6 | ProShares Ultra Nasdaq Biotechnology BIB | 0.01% | 9.6K | 1.19% |
| 7 | iShares Biotechnology ETF IBB | 0.00% | 421.4K | 0.44% |
| 8 | iShares Russell 2000 Growth ETF IWO | 0.00% | 517.3K | 0.24% |
| 9 | iShares Russell 2000 Value ETF IWN | 0.00% | 422.6K | 0.24% |
| 10 | Vanguard Russell 2000 Growth ETF VTWG | 0.00% | 49.8K | 0.06% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
1
Sells
0
Shares acquired
5.0K
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+5,000
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-06 | Lowell Matthew | Officer | P-Purchase | A | Common Stock | 40,000 | 2.19 | 87.6K | 168,376 | D | ↗ |
| 2026-03-06 | Gunstream Stephen | Director / Officer | P-Purchase | A | Common Stock | 26,000 | 2.15 | 55.8K | 269,497 | D | ↗ |
| 2026-02-15 | Terrill Damon | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 148,000 | 1.99 | 294.5K | 148,000 | D | ↗ |
| 2026-02-15 | Lowell Matthew | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 171,000 | 1.99 | 340.3K | 171,000 | D | ↗ |
| 2026-02-15 | Gunstream Stephen | Director / Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 429,000 | 1.99 | 853.7K | 429,000 | D | ↗ |
| 2025-06-27 | DEMSKI MARTHA J | Director | S-Sale | D | Common Stock | 8,000 | 5.06 | 40.5K | 12,000 | D | ↗ |
| 2025-06-17 | Vos Alexander | Director | A-Award | A | Common Stock | 54,300 | 0.00 | — | 102,472 | D | ↗ |
| 2025-06-17 | ROBERTSON BRETT | Director | A-Award | A | Common Stock | 54,300 | 0.00 | — | 102,472 | D | ↗ |
| 2025-06-17 | DEMSKI MARTHA J | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 54,300 | 5.39 | 292.7K | 54,300 | D | ↗ |
| 2025-02-27 | ROBERTSON BRETT | Director | J-Other | A | Common Stock | 5,000 | 0.00 | — | 5,000 | I | ↗ |
| 2025-02-14 | Terrill Damon | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 137,808 | 8.28 | 1.14M | 137,808 | D | ↗ |
| 2025-02-14 | Lowell Matthew | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 169,857 | 8.28 | 1.41M | 169,857 | D | ↗ |
| 2025-02-14 | Gunstream Stephen | Director / Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 393,663 | 8.28 | 3.26M | 393,663 | D | ↗ |
| 2024-07-12 | Telegraph Hill Partners IV, L.P. | 10% Owner | P-Purchase | A | Common Stock | 11,126,929 | 1.24 | 13.80M | 11,126,929 | — | ↗ |
| 2024-07-12 | Lowell Matthew | Officer | P-Purchase | A | Common Stock | 40,322 | 1.24 | 50.0K | 128,376 | — | ↗ |
| 2024-07-12 | Gunstream Stephen | Director / Officer | P-Purchase | A | Common Stock | 80,645 | 1.24 | 100.0K | 243,497 | — | ↗ |
| 2024-06-26 | Vos Alexander | Director | A-Award | A | Common Stock | 20,000 | 0.00 | — | 48,172 | — | ↗ |
| 2024-06-26 | ROBERTSON BRETT | Director | A-Award | A | Common Stock | 20,000 | 0.00 | — | 48,172 | — | ↗ |
| 2024-06-26 | DEMSKI MARTHA J | Director | A-Award | A | Common Stock | 20,000 | 0.00 | — | 20,000 | — | ↗ |
| 2023-11-30 | McNamara Robert | Director | D-Return | D | Non-Qualified Stock Option (right to buy) | 31,959 | 16.00 | 511.3K | 0 | — | ↗ |
| 2023-11-30 | Gelhaus Ken | Officer | P-Purchase | A | Common Stock | 3,587 | 1.73 | 6.2K | 22,924 | — | ↗ |
| 2023-11-14 | Hood Lisa | Officer | J-Other | D | Common Stock | 15,000 | 0.00 | — | 18,834 | — | ↗ |
| 2023-09-19 | Terrill Damon | Officer | P-Purchase | A | Common Stock | 27,027 | 1.85 | 50.0K | 41,027 | — | ↗ |
| 2023-09-19 | Telegraph Hill Partners IV, L.P. | 10% Owner | P-Purchase | A | Common Stock | 6,917,837 | 1.85 | 12.80M | 21,859,660 | — | ↗ |
| 2023-09-19 | MACKOWSKI J MATTHEW | Director | P-Purchase | A | Common Stock | 810,810 | 1.85 | 1.50M | 810,810 | — | ↗ |
| 2023-09-19 | Lowell Matthew | Officer | P-Purchase | A | Common Stock | 54,054 | 1.85 | 100.0K | 88,054 | — | ↗ |
| 2023-09-19 | Gunstream Stephen | Director / Officer | P-Purchase | A | Common Stock | 54,054 | 1.85 | 100.0K | 162,852 | — | ↗ |
| 2023-08-31 | McNamara Robert | Director | D-Return | D | Common Stock | 18,815 | 0.00 | — | 9,357 | — | ↗ |
| 2023-08-31 | DEMSKI MARTHA J | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-06-13 | Hood Lisa | Officer | S-Sale | D | Common Stock | 11,400 | 3.80 | 43.3K | 33,834 | — | ↗ |
| 2023-06-02 | Vos Alexander | Director | A-Award | A | Common Stock | 18,815 | 0.00 | — | 28,172 | — | ↗ |
| 2023-06-02 | ROBERTSON BRETT | Director | A-Award | A | Common Stock | 18,815 | 0.00 | — | 28,172 | — | ↗ |
| 2023-06-02 | McNamara Robert | Director | A-Award | A | Common Stock | 18,815 | 0.00 | — | 28,172 | — | ↗ |
| 2023-05-26 | Davis Ted | Director / 10% Owner | P-Purchase | A | Common Stock | 1,000 | 3.17 | 3.2K | 1,888,419 | — | ↗ |
| 2023-05-26 | Davis Irene | Director / 10% Owner | P-Purchase | A | Common Stock | 1,000 | 3.17 | 3.2K | 1,888,419 | — | ↗ |
| 2023-05-17 | Hood Lisa | Officer | S-Sale | D | Common Stock | 3,119 | 2.04 | 6.4K | 45,234 | — | ↗ |
| 2023-05-12 | Hood Lisa | Officer | P-Purchase | A | Common Stock | 3,119 | 1.67 | 5.2K | 48,353 | — | ↗ |
| 2023-05-12 | Gunstream Stephen | Director / Officer | P-Purchase | A | Common Stock | 4,665 | 1.67 | 7.8K | 108,798 | — | ↗ |
| 2023-05-12 | Gelhaus Ken | Officer | P-Purchase | A | Common Stock | 3,915 | 1.67 | 6.5K | 19,337 | — | ↗ |
| 2023-02-27 | Terrill Damon | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 28,000 | 5.41 | 151.5K | 28,000 | — | ↗ |
| 2023-02-27 | Lowell Matthew | Officer | A-Award | A | Common Stock | 14,000 | 0.00 | — | 34,000 | — | ↗ |
| 2023-02-27 | Hood Lisa | Officer | A-Award | A | Common Stock | 14,000 | 0.00 | — | 45,234 | — | ↗ |
| 2023-02-27 | Gunstream Stephen | Director / Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 86,250 | 5.41 | 466.6K | 86,250 | — | ↗ |
| 2023-02-27 | Gelhaus Ken | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 28,000 | 5.41 | 151.5K | 28,000 | — | ↗ |
| 2022-11-15 | Terrill Damon | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 30,000 | 0.00 | — | 30,000 | — | ↗ |
| 2022-11-15 | Lowell Matthew | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 33,093 | 0.00 | — | 33,093 | — | ↗ |
| 2022-11-15 | Hood Lisa | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 40,498 | 0.00 | — | 40,498 | — | ↗ |
| 2022-11-15 | Gunstream Stephen | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 87,500 | 0.00 | — | 87,500 | — | ↗ |
| 2022-11-15 | Gelhaus Ken | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 72,500 | 0.00 | — | 72,500 | — | ↗ |
| 2022-11-14 | Hood Lisa | Officer | P-Purchase | A | Common Stock | 2,046 | 4.23 | 8.7K | 33,280 | — | ↗ |
| 2022-11-14 | Gunstream Stephen | Officer | P-Purchase | A | Common Stock | 1,716 | 4.23 | 7.3K | 61,008 | — | ↗ |
| 2022-11-14 | Gelhaus Ken | Officer | P-Purchase | A | Common Stock | 1,422 | 4.23 | 6.0K | 1,422 | — | ↗ |
| 2022-09-30 | Gunstream Stephen | Officer | M-Exempt | A | Common Stock | 40,000 | 0.84 | 33.5K | 58,000 | — | ↗ |
| 2022-09-01 | Lowell Matthew | Officer | P-Purchase | A | Common Stock | 10,000 | 4.61 | 46.1K | 20,000 | — | ↗ |
| 2022-08-24 | MACKOWSKI J MATTHEW | Director | P-Purchase | A | Common Stock | 5,000 | 4.97 | 24.9K | 5,000 | — | ↗ |
| 2022-08-16 | Grossman Paul David | Director | P-Purchase | A | Common Stock | 4,386 | 5.62 | 24.7K | 9,212 | — | ↗ |
| 2022-08-15 | Gunstream Stephen | Officer | P-Purchase | A | Common Stock | 18,000 | 5.13 | 92.3K | 18,000 | — | ↗ |
| 2022-08-15 | Grossman Paul David | Director | P-Purchase | A | Common Stock | 4,826 | 5.15 | 24.8K | 4,826 | — | ↗ |
| 2022-06-02 | Vos Alexander | Director | A-Award | A | Common Stock | 9,357 | 0.00 | — | 9,357 | — | ↗ |
| 2022-06-02 | ROBERTSON BRETT | Director | A-Award | A | Common Stock | 9,357 | 0.00 | — | 9,357 | — | ↗ |
| 2022-06-02 | McNamara Robert | Director | A-Award | A | Common Stock | 9,357 | 0.00 | — | 9,357 | — | ↗ |
| 2022-05-20 | Lowell Matthew | Officer | P-Purchase | A | Common Stock | 10,000 | 9.45 | 94.5K | 10,000 | — | ↗ |
| 2022-05-13 | Hood Lisa | Officer | P-Purchase | A | Common Stock | 772 | 10.93 | 8.4K | 31,234 | — | ↗ |
| 2022-05-13 | Gunstream Stephen | Officer | P-Purchase | A | Common Stock | 1,292 | 10.93 | 14.1K | 1,292 | — | ↗ |
| 2022-02-15 | Terrill Damon | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 60,000 | 15.09 | 905.4K | 60,000 | — | ↗ |
| 2022-02-15 | Lowell Matthew | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 60,000 | 15.09 | 905.4K | 60,000 | — | ↗ |
| 2022-02-15 | Hood Lisa | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 60,000 | 15.09 | 905.4K | 60,000 | — | ↗ |
| 2022-02-15 | Gunstream Stephen | Director / Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 175,000 | 15.09 | 2.64M | 175,000 | — | ↗ |
| 2022-02-15 | Gelhaus Ken | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 60,000 | 15.09 | 905.4K | 60,000 | — | ↗ |
| 2022-02-04 | Hood Lisa | Officer | M-Exempt | A | Common Stock | 30,462 | 1.85 | 56.2K | 30,462 | — | ↗ |
| 2021-11-17 | Gelhaus Ken | Officer | A-Award | A | Stock Option (Right to buy) | 85,000 | 25.10 | 2.13M | 85,000 | — | ↗ |
| 2021-11-15 | Gelhaus Ken | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-09-15 | Davis Ted | Director / 10% Owner | P-Purchase | A | Common Stock | 1,429 | 27.08 | 38.7K | 1,886,419 | — | ↗ |
| 2021-09-08 | Davis Ted | Director / 10% Owner | P-Purchase | A | Common Stock | 1,300 | 22.61 | 29.4K | 1,884,990 | — | ↗ |
| 2021-08-25 | Davis Ted | Director / 10% Owner | P-Purchase | A | Common Stock | 9,090 | 19.95 | 181.3K | 1,883,690 | — | ↗ |
| 2021-06-28 | Telegraph Hill Partners IV, L.P. | 10% Owner | C-Conversion | A | Common Stock | 2,570,862 | 0.00 | — | 2,570,862 | — | ↗ |
| 2021-06-24 | Vos Alexander | Director | A-Award | A | Stock Option (Right to buy) | 44,251 | 16.00 | 708.0K | 44,251 | — | ↗ |
| 2021-06-24 | Terrill Damon | Officer | — | D | Employee Stock Option (Right to buy) | 174,337 | 0.84 | 145.9K | 0 | — | ↗ |
| 2021-06-24 | ROBERTSON BRETT | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-06-24 | McNamara Robert | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-06-24 | MACKOWSKI J MATTHEW | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-06-24 | Lowell Matthew | Officer | — | D | Employee Stock Option (Right to Buy) | 196,833 | 5.44 | 1.07M | 0 | — | ↗ |
| 2021-06-24 | Hood Lisa | Officer | — | D | Employee Stock Option (Right to Buy) | 112,476 | 1.85 | 207.6K | 0 | — | ↗ |
| 2021-06-24 | Herzick Alexander C. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-06-24 | Gunstream Stephen | Director / Officer | — | D | Employee Stock Option (Right to buy) | 231,719 | 0.84 | 193.9K | 0 | — | ↗ |
| 2021-06-24 | Grossman Paul David | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-06-24 | Goodwin Neal | Officer | — | D | Employee Stock Option (Right to buy) | 74,984 | 1.85 | 138.4K | 0 | — | ↗ |
| 2021-06-24 | Davis Ted | Director | — | I | Common Stock | 0 | 0.00 | — | 1,687,140 | — | ↗ |
| 2019-01-14 | Telegraph Hill Partners IV, L.P. | 10% Owner | — | I | Series A Convertible Preferred Stock | 2,570,862 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-95.3K
Shares Outstanding
53.61M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Stephen Gunstream | President, Chief Executive Officer & Director | 937.8K | male |
| Matthew C. Lowell | Chief Financial Officer | 599.2K | male |
| Damon A. Terrill | General Counsel, Chief Compliance Officer & Secretary | 578.9K | male |
| Jennifer Henry | Senior Vice President of Marketing | — | female |
ESG Rating
ESG Score History DRUG MANUFACTURERS - SPECIALTY & GENERIC
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for TKNO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
